DANS LES MÉDIAS

Découvrez comment Sorintellis contribue à façonner l’avenir grâce à ses projets, ses partenariats et ses innovations. Consultez les articles et les publications médiatiques qui mettent en lumière nos réalisations et nos avancées les plus récentes. 
Couverture médiatique

Vantage BioTrials Joins AI Collaboration to Advance Clinical Trial Intelligence and Improve Trial Execution with TrialsBank™

Couverture médiatique

AI Powerhouses & Sorintellis Forge Alliance to Remake Clinical Trials

Couverture médiatique

AI Framework Uncovers Hidden Risks in Clinical Trials

Article scientifique

A Latent Risk-Aware Machine Learning Approach for Predicting Operational Success in Clinical Trials based on TrialsBank

Communiqué de presse

Sorintellis, Vantage Biotrials, Université de Montréal, Université Laval and IVADO Announce Strategic Scientific Collaboration to Advance a Clinical Trial Intelligence Layer Powered by TrialsBank™

Couverture médiatique

ADRIQ – Association pour le Développement de la Recherche et de l’Innovation du Québec dévoilent les finalistes des Prix Innovation 2025 ! Sorintellis nominé dans 2 catégories parmi les finalistes du Prix Innovation 2025.

Couverture médiatique

With 4.3M+ Tech Community Votes, HackerNoon Announces Winning Startups From Every Major City In the World

Communiqué de presse

CQDM and Sorintellis Group fund the development of an AI-powered platform to mitigate clinical trial risks

Communiqué de presse

Mila and Sorintellis Announce a Partnership to Optimize Complex Decision-Making Processes in Clinical Drug Development

Communiqué de presse

Mitacs ramps up investment in AI training and helping Canadian businesses adopt AI

Projets

Artificial intelligence-powered approach for strategic pharmaceutical portfolio management based on a priori estimation of clinical trial success evolution

Projets

Artificial intelligence-powered platform for analyzing the success of clinical trials and interpreting risk factors

Projets

Sorintellis, in collaboration with Pfizer, is advancing its ambition to develop an AI-based platform aimed at efficiently mitigating risks in clinical drug development

Communiqué de presse

Interview with Emmanuel Piffo, Sorintellis’ CEO

Projets

Development of a proof of concept of an a priori estimation of clinical trial success evolution based on machine learning

Projets

Decision-making system for strategic pharmaceutical portfolio management based on artificial intelligence

Projets

Sorintellis, IVADO, Polytechnique and Université de Montréal join forces to transform pharmaceutical portfolio management through AI with support from MITACS

Couverture médiatique

Quebec’s Rising Biotech Startups Revolutionizing Canada’s Healthcare Industry

Communiqué de presse

Sorintellis’ team was warmly welcomed at the Computer Research Institute of Montreal (CRIM) to inaugurate a pilot project

Besoin de plus d'informations?